Skip to main content
. 2022 May 21;129(2):182–188.e1. doi: 10.1016/j.anai.2022.05.014

Table 1.

Basic Clinical Characteristics for the Recruited Patients (N = 44)

Variable N (%)
Age, y (median, IQR) 55.50 (39.75-65.00)
Sex (female) 39 (88.7%)
Ethnicity
 White 35 (79.5%)
 East Asian 4 (9.1%)
 African 2 (4.5%)
 Middle East/Aboriginal/Latino 3 (6.8%)
Past medical history of any allergic reaction 44 (100%)
 Drug allergy label 44 (100%)
 Food allergy label 15 (34.1%)
Allergic rhinitis 15 (34.1%)
Asthma 9 (20.5%)
Atopic dermatitis 2 (4.5%)
Idiopathic urticaria or angioedema 8 (18.2%)
History of anaphylaxis 12 (27.3%)
Charlson Comorbidity Index score
 Mild1,2 22 (50%)
 Moderate3,4 12 (27.2%)
 Severe (≥5) 10 (22.7%)
Current medications
 Beta-blockers 3 (6.8%)
 ACE inhibitors 4 (9.1%)
 Angiotensin-receptor blockers 4 (9.1%)
 Immunosuppressive medications 5 (11.4%)
 Prednisone 2 (4.5%)
 Anticoagulants 2 (4.5%)

Abbreviations: ACE, angiotensin-converting enzyme; IQR, interquartile range.